Selzentry (Maraviroc, Celsentri)

The Basics | News & Research

Show Archived (Historical) Articles

Brand Name:	Selzentry
Generic Name:	Maraviroc, MVC
Adult Single Dose*:	One 300 mg tablet twice daily
Food & Liquid Restrictions:	None.
Drug Class:	Entry Inhibitor

From The Body's "Ask the Experts" Forums

Selzentry sounds like a groundbreaking drug. What makes it special? How will it change HIV treatment?
Will Selzentry work as well in older people as it does in young ones?
Is Selzentry suitable for someone who has hepatitis C and hemophilia in addition to HIV?

» More questions

READ FIRST:

An Overview of Selzentry (Maraviroc, Celsentri) (November 23, 2008)
To read PDF, click here
From U.S. National Institutes of Health
A Revolutionary New Way to Fight HIV/AIDS: CCR5 Inhibitors (September 2008)
Find out more about Selzentry in this special report.
From The Body
Maraviroc (Selzentry, Celsentri) (December 4, 2008)
To read PDF, click here
From AIDS InfoNet
A New Way to Fight HIV: CCR5 Inhibitors (April 30, 2008)
An interview with David Hardy, M.D.
From The Body
Selzentry (March/April 2009)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
The Basics on Maraviroc: An Interview With Joel Gallant, M.D., M.P.H. (August 6, 2007)
From The Body

The Basics

Characteristics of Fusion and Integrase Inhibitors, and CCR5 Antagonists (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents. For the full guidelines, click here (PDF).
From AIDSinfo
Patient Information About Selzentry (Maraviroc, Celsentri) (PDF) (November 2008)
From Pfizer, Inc.
Selzentry (Maraviroc) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
FDA Approves Pfizer's Antiretroviral Maraviroc (August 7, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Approval of Maraviroc (August 6, 2007)
From U.S. Food and Drug Administration

My Health Tracker

Widgets and RSS Feeds

U.S. ASO Finder

The First Man to Be Cured of AIDS: An Update on the Amazing Story -- This Month in HIV

OIs and Co-Infections and STIs -- Oh, My!

HIV Antiretrovirals in Development: An Update From ICAAC 2009

World AIDS Day 2009: Home

Back From the Brink: A Blog Entry by Thomas DeLorenzo

More >>

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.